|Bid||66.53 x 300|
|Ask||66.55 x 300|
|Day's Range||66.39 - 66.68|
|52 Week Range||62.70 - 84.88|
|PE Ratio (TTM)||16.53|
|Forward Dividend & Yield||1.85 (2.84%)|
|1y Target Est||N/A|
Shanghai Pharmaceuticals Holding Co has bid for Cardinal Health Inc's China business as the U.S. company looks to sell ahead of China's planned drug distribution reform. Shanghai Pharma submitted two non-binding bids to buy Cardinal Health China, one of the country's largest drug distributors, on July 21 and Sept. 15, it said in a filing with the Shanghai stock exchange on Wednesday. Reuters first reported in July that Cardinal Health had put its China business up for sale in a deal that could fetch between $1.2 billion and $1.5 billion.
Categories: Yahoo FinanceGet free summary analysis Our analysis is based on comparing Cardinal Health, Inc. with the following peers – McKesson Corporation, AmerisourceBergen Corporation, Henry Schein, Inc., CVS Health Corporation, Herbalife Ltd., Patterson Companies, Inc., Owens & Minor, Inc., Teleflex Incorporated, Premier Inc. Class A and Rite Aid Corporation (MCK-US, ABC-US, HSIC-US, CVS-US, HLF-US, PDCO-US, OMI-US, TFX-US, ... Read more (Read more...)
Private equity firm FountainVest Partners Co. is vying with a state-owned pharmaceutical group to acquire Cardinal Health Inc.’s Chinese distribution unit, which could fetch more than $1 billion, people ...
BT Group PLC (BT), Cardinal Health Inc. (CAH), Teva Pharmaceutical Industries Ltd (TEVA), and Chipotle Mexican Grill Inc. (CMG) have declined to their respective three-year lows.
On July 30, 2017, Cardinal Health (CAH) completed the acquisition of Medtronic’s patient recovery business for an all-cash consideration worth $6.1 billion.
In fiscal 2017, Cardinal Health’s (CAH) Medical segment reported robust demand in areas such as surgical kitting, lab services, post acute, and medical services.
Cardinal Health’s (CAH) Specialty Solutions segment provides two types of services: upstream to pharmaceutical and biopharmaceutical manufacturers and downstream to healthcare providers.
Wall Street analysts have projected Cardinal Health’s fiscal 2018 net profit margins to be 1.0%, which will be similar to what the company reported in fiscal 2017.
For fiscal 2018, Cardinal Health (CAH) has projected mid-single-digit revenue growth on a YoY basis, partially driven by the company’s high customer retention rates.
Cardinal Health (CAH) reported revenues of $130.0 billion for fiscal 2017, which is a YoY (year-over-year) rise of 7.0%.
The Zacks Analyst Blog Highlights: Cardinal Health, Penumbra, STAAR Surgical, Masimo and Smith & Nephew
Attorneys general from most states are broadening their investigation into the opioid industry as a nationwide overdose crisis continues to claim thousands of lives.
The White House is eliminating a crucial part of the Affordable Care Act. President Donald Trump wants to immediately stop payments to insurers. The administration said the government cannot legally continue to make payments. Yahoo Finance’s Alexis Christoforous and Rick Newman figure out how this will impact the insurance industry and patients.